Adhesive Medicament Delivery Device for Stable Injection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medicament delivery devices face challenges in maintaining a stable holding position during injection, leading to discomfort, wet injection sites, early device removal, and partial medicament delivery due to the need for users to counteract spring forces and manually manage adhesive covers.

Innovation Solution

A medicament delivery device with a moveable outer frame that exposes an adhesive region by removing a protective barrier as it retracts, allowing single-action adhesion to the injection site, reducing the need for users to hold the device steady and simplifying the injection process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If the device uses a manual holding mechanism during injection, then the user can control device position, but the user must apply continuous holding force which causes discomfort and may lead to early device removal

Engineering Contradiction:
Improveease of device handlingVSAvoiduser discomfort and device instability
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The adhesive attachment element automatically secures the device to the injection site without requiring the user to apply continuous holding force. The adhesive performs the securing function autonomously, allowing the user to simply hold the device briefly during attachment while the adhesive takes effect, thereby eliminating the need for sustained manual effort and reducing user discomfort.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The adhesive attachment element is applied to the injection site before needle insertion. This preliminary attachment ensures the device is securely positioned in advance, allowing the user to focus solely on the injection action without needing to simultaneously maintain device stability, thereby simplifying the overall operation and reducing user burden.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If the device requires separate steps for removing protective barrier and activating adhesion, then the adhesive can be protected until needed, but the multi-step process increases complexity and time required

Engineering Contradiction:
Improveadhesive protection until activationVSAvoidnumber of activation steps
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The protective barrier removal and adhesive activation steps are merged into a single integrated action. The protective barrier is designed to be removed by the same user motion that activates the adhesive, combining two previously separate functions into one unified step. This reduces the number of steps required while maintaining reliable adhesive protection until activation.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The protective barrier is pre-positioned to cover the adhesive region, and its removal is integrated with the activation motion. The barrier is designed to be peeled or detached as part of the same user action that engages the adhesive, so the protection is maintained until the precise moment of activation without requiring separate preparatory steps.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If the adhesive region is exposed before needle insertion, then the device can be attached to the skin, but the adhesive may become contaminated or lose effectiveness

Engineering Contradiction:
Improvedevice attachment to injection siteVSAvoidadhesive effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The protective barrier is pre-applied to the adhesive region to prevent contamination before the adhesive is activated. The barrier remains in place during device handling and transport, and is only removed at the moment of activation, ensuring the adhesive surface remains clean and effective throughout the process while still allowing timely attachment when needed.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The protective barrier serves as an intermediary layer between the adhesive and the external environment. It physically separates the adhesive from potential contaminants in the air or on surfaces, allowing the adhesive to remain protected and effective until the barrier is intentionally removed at the activation moment, at which point the adhesive can safely contact the injection site.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device ensures secure adhesion to the injection site, facilitating easier handling and complete medicament delivery without the need for users to apply holding forces, thereby reducing discomfort and ensuring full dose administration.

Implementation Method 1

an attachment element comprising an adhesive region for attaching the medicament delivery device to a surface

Methodology Applied
Scientific EffectAdhesive: Adhesive

Data Source

PatentUS12409277B1Medicament delivery device
Publication Date: 2025.09.09 GENZYME CORP
  • US12409277B1 patent drawing
  • US12409277B1 patent drawing
  • US12409277B1 patent drawing

AI summary

There is provided a medicament delivery device comprising: a main body arranged to receive a medicament cartridge; a needle for delivery of medicament from the medicament cartridge; a needle cover moveable between an initial position, in which the needle cover covers the needle, and an activated position for dispensing medicament from the medicament delivery device, wherein in the activated position the needle protrudes from a distal end of the needle cover; an outer frame, moveable relative to the main body between an extended position in which the outer frame extends past a distal end of the needle, and a retracted position in which the outer frame is moved towards the main body; an attachment element comprising an adhesive region for attaching the medicament delivery device to a surface when the needle cover is in the activated position, the attachment element comprising a protective barrier covering the adhesive region.